Trial Profile
Non-interventional PASS to Evaluate Safety of Kineret in Treatment of CAPS in Routine Clinical Care With Regard to Serious Infections, Malignancies, Injection Site Reactions, Allergic Reactions, Medication Errors Including Re-use of Syringe
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Cryopyrin-associated periodic syndromes
- Focus Adverse reactions
- Sponsors Swedish Orphan Biovitrum
- 14 Jan 2020 Status changed from active, no longer recruiting to completed.
- 18 Oct 2019 Planned End Date changed from 1 Feb 2020 to 1 Dec 2019.
- 18 Oct 2019 Planned primary completion date changed from 11 Aug 2019 to 1 Dec 2019.